Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZytronic Regulatory News (ZYT)

Share Price Information for Zytronic (ZYT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 55.00
Bid: 50.00
Ask: 60.00
Change: 0.00 (0.00%)
Spread: 10.00 (20.00%)
Open: 55.00
High: 55.00
Low: 55.00
Prev. Close: 55.00
ZYT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Trading Update and Planned Board Changes

9 Feb 2023 07:00

RNS Number : 3783P
Zytronic PLC
09 February 2023
 

Zytronic plc ("Zytronic" or the "Company", andtogether with its subsidiary, the "Group")

AGM Trading Update and Planned Board Changes

 

Zytronic, a leading specialist manufacturer of touch sensors, provides the following trading update and commentary regarding planned Board changes, ahead of the AGM being held at the Company's offices at 1.00 p.m. today.

 

AGM Trading Statement

Trading conditions for the first two months of FY23 were commented upon in the Company's FY22 Final Results announcement released 13 December 2022 ("FY22 Final Results") and remained relatively unchanged at the end of January 2023. As described more fully below and consistent with the trend outlined in the Final Results release, business development and the opportunities pipeline continue to progress positively.

 

Performance during the first four months of the current financial year has continued to be affected by the ongoing global supply chain considerations as described in the FY22 Final Results announcement and the average monthly order intake is also at levels similar to those of the second half of FY22. As the shortage of certain electronic component items persists the Group continues, by necessity, to purchase certain items either on the grey market (at higher pricing) or to cannibalise existing finished stock, due to the lack of availability and levels of allocations from original manufacturers. 

 

More pleasingly the opportunities pipeline, which was covered in some depth in the FY22 Final Results announcement, has increased to 505 'Open' opportunities, with an increase in the customer projected lifetime value ("CPLV") to £61m (30 September 2022: 484 Open opportunities and CPLV of £59m). This continues the net positive trends in these two metrics observed since July 2021 which, while remaining subject to monthly variability, are further evidence of the improving medium-term prospects for the business.

 

With regards to wages and salaries, the Group's operational management has now entered the period of wage negotiations with employee representatives for a 1 April 2023 effective date. The Company is mindful of general cost of living issues and of the significant changes to, and implications from, the proposed increases to the National Minimum and National Living Wage rates applicable from that date. These, alongside inflation considerations, have the potential to negatively impact costs over the second half of the fiscal year ahead of previous budgeting.

 

The Company's balance sheet remains strong with net cash of £6.8m as at 31 January 2023 (30 September 2022: £6.4m).

 

Outlook

As a result of the combined effects of the continuing supply chain issues and the increasingly robust opportunities pipeline, the Board anticipates a stronger second-half weighting of revenue than that observed for the last financial year. A further update will be provided at the time of the Group's interim results (for the six months ending 31 March 2023), which are expected to be released in May 2023.

 

 

Planned Board Changes

As previously noted, the Board is progressing the appointment of further new Independent Non-executive Directors ("INEDs") in order to improve the balance of Board independence in recognition of QCA Corporate Governance Code (the "QCA Code") guidelines, after the departure of the previous non-Executive Chair at the start of the FY23 fiscal year due to ill health. The Board continues to review strategies for future growth and improved shareholder value and expects to appoint recruitment agents to support its INED search in support of these goals once these are further defined and the optimal skill sets to support their delivery are identified.

 

Notwithstanding this on-going process, the Board has agreed that it is in the best interests of the Group that Mark Cambridge is able to solely concentrate on its operational requirements. To facilitate this, he will step down as Acting Executive Chair at the conclusion of the AGM and resume his prior role of CEO, with Mark Butcher (INED) being appointed to the position of Interim Non-executive Chair. The Company will update its Corporate Governance Statement on its website shortly, to reflect this change, while Mark Butcher's appointment as Chair means he would not ordinarily be expected to chair the audit and remuneration committees, this is a current practical necessity and will be resolved on the appointment of a further suitable INED or INEDs. 

 

In addition to this, the Board has agreed to the recent request of John Walter, the largest individual shareholder in the Company, to temporarily join the Board from 10 February 2023, as a Non-executive Director. John's appointment will be for a fixed-term period, concluding no later than the day prior to the posting of the notice to shareholders of the 2024 AGM. John is a former investment banker and wealth manager with over 25 years' investment experience in the public markets. Further regulatory disclosures in relation to the appointment of John Walter will be made in the Results of AGM announcement to be issued later today.

 

Although the Board recognises that John is not independent by virtue of his shareholding interest, it considers that his temporary appointment will afford it with a better balance of Non-executive impartiality in the interim and provides reasonable shareholder input into the process of seeking and concluding the appointments of new INEDs.

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014 (which forms part of domestic UK law pursuant to the European Union (Withdrawal) Act 2018).

 

Enquiries:

 

Zytronic plc

Mark Cambridge, Acting Executive Chair

Claire Smith, Group Finance Director

 

0191 414 5511

Singer Capital Markets

(Nominated Adviser and Broker)

Aubrey Powell, Alex Bond, Alex Emslie

 

020 7496 3000

About Zytronic

Zytronic is a world-renowned developer and manufacturer of a unique range of internationally award winning optically transparent interactive touch sensor overlay products for use with electronic displays in industrial, self-service and public access equipment.

Zytronic's products employ a sensing solution that is readily configurable and embedded in a laminate core that offers significant durability, environmental stability and optical enhancement benefits to system designers specific requirements.

Zytronic has continually developed process and technological know-how and IP since the late 1990's around two sensing methodologies; the first being single touch self-capacitive which Zytronic markets as PCT™ ("Projected Capacitive Technology") and the second being multi-touch, multi-user mutual-capacitive which Zytronic markets as MPCT™ ("Mutual Projected Capacitive Technology"), in which Zytronic holds five granted patents.

Zytronic operates from a single site near Newcastle-upon-Tyne in the United Kingdom. Zytronic is relatively unique in the touch eco-system as it offers a complete one-stop solution from processing internally the form and factor of the glass substrates, assembles their touch overlay products to customers specific requirements, in environmentally controlled cleanrooms and develops the bespoke firmware, software and electronic hardware to link the interactive overlays to customer's integrated systems and products.

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDDGDDRGGDGXI
Date   Source Headline
29th Feb 20246:28 pmRNSResult of AGM
29th Feb 20247:00 amRNSAGM Trading Update
23rd Jan 20243:41 pmRNSPosting of Annual Report and Notice of AGM
19th Jan 20244:24 pmRNSHolding(s) in Company
16th Jan 20241:00 pmRNSInvestor Presentation via Investor Meet Company
9th Jan 20247:00 amRNSFinal Results for the year ended 30 September 2023
18th Dec 20237:00 amRNSNotice of Results and Trading Update
15th Dec 20234:23 pmRNSHolding(s) in Company
6th Oct 20235:45 pmRNSHolding(s) in Company
2nd Aug 20238:51 amRNSHolding(s) in Company
1st Aug 20237:00 amRNSDirectorate Change
11th Jul 20234:06 pmRNSHolding(s) in Company
23rd Jun 20235:05 pmRNSHolding(s) in Company
5th Jun 202311:38 amRNSHolding(s) in Company
16th May 20237:01 amRNSInvestor Presentation on Interim Results
16th May 20237:00 amRNSInterim Results
12th May 20234:23 pmRNSHolding(s) in Company
9th May 20232:29 pmRNSHolding(s) in Company
4th May 20237:00 amRNSTrading Update
9th Feb 20234:31 pmRNSResult of AGM & Board Appointment
9th Feb 20237:00 amRNSAGM Trading Update and Planned Board Changes
11th Jan 20232:45 pmRNSPosting of Annual Report & Notice of AGM
13th Dec 20227:00 amRNSFinal Results for the year ended 30 September 2022
7th Dec 202211:00 amRNSNotice of Results & Investor Presentation
17th Nov 202210:53 amRNSHolding(s) in Company
26th Oct 202210:30 amRNSBoard Update
24th Oct 20226:05 pmRNSHolding(s) in Company
4th Oct 20228:00 amRNSBoard Update
18th Aug 20227:00 amRNSTrading Update
4th Aug 20221:51 pmRNSHolding(s) in Company
25th May 202212:09 pmRNSCompletion of Share Buyback
25th May 20227:00 amRNSPurchase of own shares
24th May 20227:00 amRNSPurchase of own shares
23rd May 20227:00 amRNSPurchase of own shares
19th May 20227:00 amRNSPurchase of own shares
18th May 20227:00 amRNSPurchase of own shares
17th May 20227:00 amRNSInterim Results
17th May 20227:00 amRNSPurchase of own shares
13th May 20227:00 amRNSPurchase of own shares
12th May 20225:16 pmRNSInvestor Presentation on Interim Results
12th May 20227:00 amRNSPurchase of own shares
10th May 202212:37 pmRNSNotice of Interim Results
10th May 20227:00 amRNSPurchase of own shares
6th May 20225:38 pmRNSPurchase of own shares
5th May 20227:00 amRNSPurchase of own shares
29th Apr 20227:00 amRNSPurchase of own shares
27th Apr 20227:00 amRNSPurchase of own shares
21st Apr 20227:00 amRNSPurchase of own shares
7th Apr 20227:00 amRNSPurchase of Own Shares
31st Mar 20227:00 amRNSPurchase of Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.